tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports
Want to see ETON full AI Analyst Report?

Eton Pharmaceuticals (ETON) Income Statement

557 Followers

Eton Pharmaceuticals Income Statement

Last quarter (Q4 2025), Eton Pharmaceuticals's total revenue was $21.28M, an increase of 82.72% from the same quarter last year. In Q4, Eton Pharmaceuticals's net income was $1.48M. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 79.95M$ 39.01M$ 31.64M$ 21.25M$ 21.83M
Gross Profit
$ 42.74M$ 23.41M$ 21.06M$ 14.32M$ 19.21M
Operating Expenses
$ 42.67M$ 26.01M$ 22.25M$ 22.58M$ 20.70M
Depreciation and Amortization
$ 4.04M$ 1.15M$ 901.00K$ 1.77M$ 462.00K
EBITDA
$ 4.12M$ -1.45M$ -291.00K$ -6.49M$ -1.03M
Operating Income
$ 72.00K$ -2.60M$ -1.19M$ -8.26M$ -1.50M
Other Income/Expenses
$ -4.63M$ -1.21M$ 503.00K$ -761.00K$ -460.00K
Pretax Income
$ -4.56M$ -3.81M$ -689.00K$ -9.02M$ -1.96M
Net Income
$ -4.60M$ -3.82M$ -936.00K$ -9.02M$ -1.96M
Per Share Metrics
Basic EPS
$ -0.17$ -0.15$ -0.04$ -0.36$ -0.08
Diluted EPS
$ -0.17$ -0.15$ -0.04$ -0.36$ -0.08
Weighted Average Shares Outstanding
 26.91M 25.89M 25.64M 25.15M 25.21M
Weighted Average Shares Outstanding (Diluted)
 26.91M 25.89M 25.65M 25.15M 25.21M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History